$1.5M
3.0x
Subscribe Free
Read the full deal writeup
Sign up for a free Accredited account to read the editorial writeup, financials, and broker contact for this deal.
Get Free AccessFull Editorial Writeup
Sale Pending This opportunity’s trademarked products have the exclusive feature of holding diabetic sensors in place without sticking to the sensor itself. The patches are sold through their website, Amazon FBA, and have achieved distribution in brick-and-mortar outlets as well. The success of...
Why we like it
- Cash conversion looks strong with $1.46M in cash flow on a 3.01x multiple, suggesting this is a real cash-generating business rather than a growth story with inflated metrics. The multiple implies either conservative accounting or room for optimization, which creates upside potential for an operator buyer.
- The trademark protection and unique non-adhesive feature creates a defensible product moat in a large and growing market. Diabetic patients represent a sticky, recurring customer base that needs these products regularly, creating predictable demand patterns.
- Multi-channel distribution through web, Amazon, and retail demonstrates the product has found product-market fit across different customer acquisition channels. This diversification reduces platform risk while providing multiple levers for growth acceleration.
- The diabetes management market has strong secular tailwinds with increasing diagnosis rates and adoption of continuous glucose monitoring devices. As CGM usage grows, the addressable market for sensor accessories expands proportionally without additional customer education.
How to improve it
- Audit the trademark and IP portfolio immediately to understand the scope of protection and identify additional filing opportunities. Map out competitive products and file continuation patents where possible to strengthen the moat around the core innovation.
- Analyze Amazon FBA performance data to optimize listings, pricing, and inventory management. Most small brands leave significant money on the table through poor keyword optimization, suboptimal pricing strategies, and inventory stockouts.
- Expand the product line to adjacent diabetic accessories and comfort products for CGM users. Customer acquisition cost is already paid, so introducing complementary products can dramatically increase lifetime value and purchase frequency.
- Implement subscription and auto-replenishment programs across all channels to increase customer stickiness and improve cash flow predictability. Diabetic patients need these products regularly, making this a natural subscription business model.
- Build direct relationships with endocrinologists, diabetes educators, and CGM manufacturers for professional channel distribution. Medical professional recommendations carry significant weight in this market and command premium pricing.
- Launch international expansion starting with English-speaking markets where diabetes rates are high. The product likely ships easily and the marketing assets can be leveraged across similar markets with minimal localization.
- Develop a robust email and content marketing program targeting newly diagnosed diabetics and CGM users. This demographic actively seeks solutions online and educational content drives high-intent traffic.
- Negotiate better terms with existing retail partners and pursue additional pharmacy and medical supply chain distribution. Brick-and-mortar placement in high-traffic medical locations can drive significant volume growth.
Diligence notes
- Verify the trademark claims and IP protection scope through patent attorney review. Understand exactly what is protected and what competitive advantages are legally defensible versus just first-mover advantage in the market.
- Request detailed breakdown of revenue by channel and customer acquisition costs for each. Amazon FBA margins can vary wildly, and retail distribution terms may be unprofitable if not negotiated properly by inexperienced operators.
- Analyze customer retention and repurchase patterns to validate the recurring revenue assumption. If customers are one-time buyers or switching to alternatives frequently, the business model is less attractive than it appears.
- Review supplier relationships and manufacturing agreements to understand supply chain risks and cost structure flexibility. Medical device manufacturing often involves regulatory compliance costs and quality control requirements that can be expensive to maintain.